The proportion of children who received the third dose of the pentavalent vaccine (Penta 3) in Kwara has increased from 34.9 per cent in 2024 to...
The Africa Centres for Disease Control and Prevention (Africa CDC) has criticised the lack of investment in developing a vaccine against the Bundibugyo strain of Ebola,...
Gavi, the Vaccine Alliance, says 9.5 million children in 57 supported countries received no routine vaccine in 2025, despite gains in global immunisation. The figure, described...
Nigeria has called for a more equitable global pandemic preparedness system, urging increased financing, technology transfer and stronger manufacturing capacity in Africa to enable developing countries...
The Democratic Republic of the Congo (DRC) has received an initial allocation of 70,000 doses of the Ervebo Ebola vaccine to support the response to the...
The World Health Organisation (WHO) has recommended a Phase III trial of an Ebola vaccine to test whether it can protect against Bundibugyo virus disease. WHO...
The World Health Organisation (WHO) has recommended that a vaccine called Ervebo be prioritised for a randomised clinical trial against Bundibugyo virus disease in the Democratic...
The World Health Organisation (WHO) has recommended that a vaccine called Ervebo be prioritised for a randomised clinical trial against Bundibugyo virus disease in the Democratic...
The Coalition for Epidemic Preparedness Innovations (CEPI) has announced the start of the world’s first human clinical trial of a vaccine developed specifically against the Bundibugyo...
The Coalition for Epidemic Preparedness Innovations (CEPI) has awarded $1.9 million to accelerate the development of a vaccine candidate against the Bundibugyo ebolavirus, as global health...